— Poster presentation selected for the poster discussion session (Abstract No.: PA-200): in a first-in-human study in 9 heavily pretreated, high-risk patients with relapsed/refractory multiple myeloma or plasma cell leukemia, RD140, a fully human BCMA/GPRC5D dual-targeted FasT CAR-T,...
Hence then, the article about 2026 ims iaso bio presents first in human phase 1 data of rd140 a fully human bcma gprc5d dual targeted fast car t was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( 2026 IMS .. IASO Bio Presents First-in-Human Phase 1 Data of RD140, a Fully Human BCMA/GPRC5D Dual-Targeted FasT CAR-T )
Also on site :
- ‘The Lion King’ Director Rob Minkoff To Develop & Exec Produce Family Pic ‘Storm Dogs’ From Tilly Norwood Creator Particle 6
- Dr. Scholl’s ‘Wonderfully Supportive’ Slip-On Sneakers Require Zero Break-In and Come in Over 20 Styles
- The Drive-In, Streaming Platform Where Indie Filmmakers Keep IP, Audience and Money, Sets Launch (EXCLUSIVE)